116 related articles for article (PubMed ID: 8435337)
41. Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B study.
Stock W; Westbrook CA; Peterson B; Arthur DC; Szatrowski TP; Silver RT; Sher DA; Wu D; Le Beau MM; Schiffer CA; Bloomfield CD
J Clin Oncol; 1997 Jan; 15(1):26-36. PubMed ID: 8996121
[TBL] [Abstract][Full Text] [Related]
42. The bcr-abl gene in chronic myelogenous leukaemia.
Sawyers CL
Cancer Surv; 1992; 15():37-51. PubMed ID: 1451113
[TBL] [Abstract][Full Text] [Related]
43. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
[TBL] [Abstract][Full Text] [Related]
44. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Rubin CM; Carrino JJ; Dickler MN; Leibowitz D; Smith SD; Westbrook CA
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2795-9. PubMed ID: 2833755
[TBL] [Abstract][Full Text] [Related]
45. Establishment and characterization of a new Ph1-positive ALL cell line (ALL/MIK) presenting bcr gene rearrangement on bcr-2 and ALL-type bcr/abl transcript: suggestion of in vitro differentiation to monocytoid lineage.
Higa T; Okabe M; Kunieda Y; Kodama S; Itaya T; Kurosawa M; Sakurada K; Maekawa I; Shoji M; Kasai M
Leuk Lymphoma; 1994 Jan; 12(3-4):287-96. PubMed ID: 8167560
[TBL] [Abstract][Full Text] [Related]
46. Molecular abnormalities of bcr gene in some Indian patients with chronic myeloid leukaemia.
Chandrasekaran R; Murthy PB
Indian J Med Res; 1996 May; 103():267-71. PubMed ID: 8707363
[TBL] [Abstract][Full Text] [Related]
47. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML.
Mills KI; Sproul AM; Burnett AK
Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349
[TBL] [Abstract][Full Text] [Related]
48. Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival.
Shepherd P; Suffolk R; Halsey J; Allan N
Br J Haematol; 1995 Mar; 89(3):546-54. PubMed ID: 7734353
[TBL] [Abstract][Full Text] [Related]
49. Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy.
Dewald GW; Wyatt WA; Silver RT
Leuk Lymphoma; 1999 Aug; 34(5-6):481-91. PubMed ID: 10492071
[TBL] [Abstract][Full Text] [Related]
50. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
[TBL] [Abstract][Full Text] [Related]
51. Lack of bcr rearrangement in juvenile chronic myeloid leukemia.
Toren A; Mandel M; Amariglio N; Hakim Y; Brok-Simoni F; Rechavi G; Neumann Y; Ramot B
Med Pediatr Oncol; 1991; 19(6):493-5. PubMed ID: 1683680
[TBL] [Abstract][Full Text] [Related]
52. Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia.
González FA; Villegas A; Ferro MT; Cabello P; Morales D; Perez J; Martinez R
Br J Haematol; 1993 Jun; 84(2):351-2. PubMed ID: 8398844
[TBL] [Abstract][Full Text] [Related]
53. BCR gene recombines with genomically distinct sites on band 11Q13 in complex BCR-ABL translocations of chronic myeloid leukemia.
Morris C; Jeffs A; Smith T; McDonald M; Board P; Kennedy M; Fitzgerald P
Oncogene; 1996 Feb; 12(3):677-85. PubMed ID: 8637725
[TBL] [Abstract][Full Text] [Related]
54. A unique BCR-ABL1 transcript with the insertion of intronic sequence from BCR and ABL1 genes in a patient with Philadelphia-positive chronic myeloid leukemia: a case study.
Sadia H; Siddiqui RT; Nasim A
Cancer Genet Cytogenet; 2010 Aug; 201(1):57-61. PubMed ID: 20633771
[TBL] [Abstract][Full Text] [Related]
55. Further evidence for the lack of correlation between the breakpoint site within M-BCR and CML prognosis and for the occasional involvement of p53 in transformation.
Aguiar RC; Dahia PL; Bendit I; Beitler B; Dorlhiac P; Bydlowski S; Chamone D
Cancer Genet Cytogenet; 1995 Oct; 84(2):105-12. PubMed ID: 8536222
[TBL] [Abstract][Full Text] [Related]
56. Cancer genetics. Imprinting in leukaemia.
Reik W
Nature; 1992 Oct; 359(6394):362-3. PubMed ID: 1406944
[No Abstract] [Full Text] [Related]
57. A patient with marked leucocytosis, t(8;21), absent Philadelphia chromosome, but rearranged BCR gene.
Cheng G; Ha SY; Liu HW; Kwong YL; Li CK; Chan LC
Br J Haematol; 1992 Sep; 82(1):171-2. PubMed ID: 1419792
[No Abstract] [Full Text] [Related]
58. Philadelphia positive acute leukaemia with minor breakpoint cluster rearrangement may be a stem cell disease.
Jackson GH; Middleton P; Prince R; Bown N; Kernahan J; Reid MM
Br J Haematol; 1992 May; 81(1):77-80. PubMed ID: 1520629
[TBL] [Abstract][Full Text] [Related]
59. The BCR gene and philadelphia chromosome-positive leukemogenesis.
Laurent E; Talpaz M; Kantarjian H; Kurzrock R
Cancer Res; 2001 Mar; 61(6):2343-55. PubMed ID: 11289094
[No Abstract] [Full Text] [Related]
60. Molecular diagnosis of chronic myeloid leukemia using a 3'bcr probe.
Berthéas MF; Vindimian M; Ollagnon G; Pomier G; Jaubert J; Vasselon C; Reynaud J; Heally JC; Le Petit JC; Brizard CP
Nouv Rev Fr Hematol (1978); 1989; 31(6):393-5. PubMed ID: 2616268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
